201 related articles for article (PubMed ID: 16953546)
1. [The cardiorenal anemia syndrome and treatment with EPO].
Karle H; Hansen NE
Ugeskr Laeger; 2006 Aug; 168(33):2686. PubMed ID: 16953546
[No Abstract] [Full Text] [Related]
2. Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.
Iaina A; Silverberg DS; Wexler D
Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):95-100. PubMed ID: 16265380
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.
van der Putten K; Braam B; Jie KE; Gaillard CA
Nat Clin Pract Nephrol; 2008 Jan; 4(1):47-57. PubMed ID: 18094727
[TBL] [Abstract][Full Text] [Related]
4. The cardio-renal anemia syndrome.
Iaina A; Silverberg DS; Wexler D; Iaina Nomy L
Med Pregl; 2007; 60 Suppl 2():145-50. PubMed ID: 18928182
[TBL] [Abstract][Full Text] [Related]
5. Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?
Pagourelias ED; Koumaras C; Kakafika AI; Tziomalos K; Zorou PG; Athyros VG; Karagiannis A
Angiology; 2009; 60(1):74-81. PubMed ID: 18413330
[TBL] [Abstract][Full Text] [Related]
6. [The cardiorenal syndrome and erythropoietin].
Kes P; Basić-Jukić N; Jurić I; Basić-Kes V
Acta Med Croatica; 2008; 62 Suppl 1():21-31. PubMed ID: 18578329
[TBL] [Abstract][Full Text] [Related]
7. Use of erythropoietin in heart failure management.
Caiola K; Cheng JW
Ann Pharmacother; 2004 Dec; 38(12):2145-9. PubMed ID: 15494385
[TBL] [Abstract][Full Text] [Related]
8. Erythropoiesis-stimulating agents in kidney and cardiac disease.
Fluck R
Br J Hosp Med (Lond); 2006 Oct; 67(10):533-7. PubMed ID: 17069130
[No Abstract] [Full Text] [Related]
9. Recombinant human Epo treatment: beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: "Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance by Pappas et al.".
Belonje AM; de Boer RA; Voors AA
Cardiovasc Drugs Ther; 2008 Feb; 22(1):1-2. PubMed ID: 18219567
[No Abstract] [Full Text] [Related]
10. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with cardiorenal anemia syndrome.
Leszek P; Kruszewski M
Am Heart J; 2008 Mar; 155(3):e25; author reply e19. PubMed ID: 18294469
[No Abstract] [Full Text] [Related]
11. [The cardiorenal syndrome: an emerging renal disease].
Fabbian F
G Ital Nefrol; 2007; 24(2):108. PubMed ID: 17458823
[No Abstract] [Full Text] [Related]
12. EPO--one year later. Fighting anemia in the courtroom.
Riley JB; Pristave RJ
Nephrol News Issues; 1990 May; 4(5):27. PubMed ID: 2348877
[No Abstract] [Full Text] [Related]
13. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
[TBL] [Abstract][Full Text] [Related]
14. EPO--one year later. Effects of EPO on nutritional status in CRF.
Schiro KB
Nephrol News Issues; 1990 May; 4(5):26, 34. PubMed ID: 2348876
[No Abstract] [Full Text] [Related]
15. Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome.
Palazzuoli A; Gallotta M; Iovine F; Nuti R; Silverberg DS
Int J Clin Pract; 2008 Feb; 62(2):281-6. PubMed ID: 18081797
[TBL] [Abstract][Full Text] [Related]
16. [The cardio-renal anemia syndrome: what is it? With a focus on congestive heart failure].
Petersen H; Jensen KE; Haghfelt TH
Ugeskr Laeger; 2006 May; 168(19):1864-7. PubMed ID: 16756804
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors.
Jie KE; Verhaar MC; Cramer MJ; van der Putten K; Gaillard CA; Doevendans PA; Koomans HA; Joles JA; Braam B
Am J Physiol Renal Physiol; 2006 Nov; 291(5):F932-44. PubMed ID: 16885153
[TBL] [Abstract][Full Text] [Related]
18. The lessons of EPO rehabilitation.
Coutts L
Nephrol News Issues; 1990 May; 4(5):5, 28. PubMed ID: 2348878
[No Abstract] [Full Text] [Related]
19. [Cardiorenal anemia syndrome (review)].
Minasyan A
Georgian Med News; 2012 Dec; (213):17-21. PubMed ID: 23293227
[TBL] [Abstract][Full Text] [Related]
20. EPO--one year later. The challenges for the social worker.
Antonoff A
Nephrol News Issues; 1990 May; 4(5):24, 29. PubMed ID: 2348875
[No Abstract] [Full Text] [Related]
[Next] [New Search]
